Key Takeaway: Danielle Flannery joined Immuneering's clinical team in October 2022, bringing extensive experience from her previous roles in pediatrics and dermatology. She has worked as a Lead Medical Communications Specialist at a clinical research organization, emphasizing reporting and patient education. Flannery holds a bachelor's degree in international studies and public health from Indiana University.
Price reaction · baseline $6.73 (2025-12-26 close) · 12 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%
Market Sentiment Analysis
POSITIVE FACTORS
Ms. Flannery has diverse clinical experience.
She has a strong background in pediatrics and dermatology.
Her role focuses on crucial areas like product training and patient education.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor
Full Press Release Details
Ms. Flannery joined Immuneering’s clinical team in October 2022. Prior to joining Immuneering, she held a variety of clinical positions in the pediatrics and dermatology fields before joining a clinical research organization as Lead Medical Communications Specialist with a focus on reporting, product training and patient education. Ms. Flannery earned a bachelor’s degree in international studies and public health from Indiana University.
Frequently Asked Questions
When did Danielle Flannery join Immuneering?
Danielle Flannery joined Immuneering's clinical team in October 2022.
What is Flannery's background in healthcare?
She has experience in pediatrics, dermatology, and clinical research.
What degree does Danielle Flannery hold?
She earned a bachelor's degree in international studies and public health.
What was Flannery's role before Immuneering?
She was a Lead Medical Communications Specialist at a clinical research organization.